Collins Helen Louise Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$525,960.45

Insider Activity of Collins Helen Louise

According to the SEC Form 4 filings, Collins Helen Louise, being in a position of

  1. CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 160000 shares for $5.33M,
    over all time since 2024-04-11, has bought 0 shares, and sold 180816 shares for $5.85M.

Biography of Collins Helen Louise

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,328,31011100

Comparison of Insiders on Amount of Buys and Sells

2026-10-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
5,000
0.0068%
$38.47$192,342+12.89%
2026-08-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
5,000
0.0074%
$58.59$292,931-22.39%
2026-07-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
5,000
0.0069%
$52.67$263,373-0.7%
2026-06-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
5,000
0.008%
$43.80$219,017+13.39%
2026-05-18SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
5,000
0.0082%
$39.79$198,971+23.95%
2026-04-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
5,000
0.0083%
$47.67$238,352-4.16%
2026-03-25SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
40,000
0.0661%
$35.10$1.4M+27.79%
2026-03-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
5,000
0.0084%
$27.76$138,800+62.41%
2026-03-10SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
10,129
0.0173%
$30.19$305,827+48.48%
2026-03-09SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
29,871
0.0513%
$30.02$896,811+50.96%
2026-02-17SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
45,000
0.076%
$26.17$1.18M+69.71%
2024-10-18SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
816
0.0021%
$30.00$24,482-27.97%
2024-04-11SaleEnliven Therapeutics, Inc.
ELVN
CHIEF MEDICAL OFFICER
20,000
0.0421%
$25.07$501,478-5.29%
Total: 13
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.